| 期刊簡介 | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | Journal of Cardiovascular Computed Tomography LetPub Score 6.2
50 ratings
Rate
Reputation 7.5 Influence 5.0 Speed 7.0 | ||||||||||||||||||||
| 期刊簡稱 | J CARDIOVASC COMPUT | ||||||||||||||||||||
| ISSN | 1934-5925 | ||||||||||||||||||||
| E-ISSN | 1876-861X | ||||||||||||||||||||
| h-index | 44 | ||||||||||||||||||||
| CiteScore |
| ||||||||||||||||||||
| 自引率 (2023-2024) | 10.90%自引率趨勢 | ||||||||||||||||||||
| 掲載範囲 |
| ||||||||||||||||||||
| 官方網站 | http://www.journalofcardiovascularct.com/ | ||||||||||||||||||||
| 在線稿件提交 | https://www.editorialmanager.com/JCCT | ||||||||||||||||||||
| 開放訪問 | No | ||||||||||||||||||||
| 出版商 | Elsevier Inc. | ||||||||||||||||||||
| 主題領域 | CARDIAC & CARDIOVASCULAR SYSTEMS | ||||||||||||||||||||
| 出版國/地區 | UNITED STATES | ||||||||||||||||||||
| 發行頻率 | |||||||||||||||||||||
| 創刊年 | 0 | ||||||||||||||||||||
| 每年文章數 | 52每年文章數趨勢 | ||||||||||||||||||||
| 黃金OA百分比 | 18.97% | ||||||||||||||||||||
| Web of Science 四分位 （ 2023-2024） | WOS Quartile: Q1
| ||||||||||||||||||||
| 索引 (SCI or SCIE) | Science Citation Index Expanded | ||||||||||||||||||||
| 鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1934-5925%5BISSN%5D | ||||||||||||||||||||
| 平均審稿時間 * | 來自出版商的數據: 來自作者的數據: >12 Week(s), or Invited contributions | ||||||||||||||||||||
| 競爭力 * | 來自作者的數據: Moderate | ||||||||||||||||||||
| 參考鏈接 |
| ||||||||||||||||||||
| *所有的審稿過程指標，如接受率和審稿速度，僅限於用戶提交的稿件。因此，這些指標可能無法準確反映期刊的競爭力或速度。 | |||||||||||||||||||||
|
| |
| 首頁 上一頁 1 下一頁 末頁 (頁 | |
| [Journal of Cardiovascular Computed Tomography] 的評論 | 撰寫評論 |
| 作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定＆不明 撰寫評論 |
2021-12-30 23:18:54 評論於 Due to the many factors that can affect the efficacy of animal experiments or clinical treatments, unless the results clearly show a synergistic effect that significantly increases the sum of the effectiveness of each drug, it is generally referred to as an additive effect  (0) 讚！ | 维尔娜菲茨杰拉德  |
| 作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定＆不明 撰寫評論 |
2021-12-30 19:22:47 評論於 ORCID is an open researcher and contributor identifier. ORCID iD is a unique and persistent academic identity for authors, distinguishing them from other researchers and recording all of their relevant research activities. It is necessary to log in to each author's account and then make associations within the account information (0) 讚！ | 维尔娜菲茨杰拉德 |
| 作者: 龙鳞孝礼 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定＆不明 撰寫評論 |
2021-12-27 15:38:26 評論於 How to determine whether two drugs have synergistic effects or additive effects? (0) 讚！ | 龙鳞孝礼 |
| 作者: 陶宜三岁啦 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定＆不明 撰寫評論 |
2021-12-26 20:01:05 評論於 How to add ORCIDID if the article has been published without it? (0) 讚！ | 陶宜三岁啦 |
| 作者: 沛容来了 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定＆不明 撰寫評論 |
2020-03-12 12:05:24 評論於 The article was submitted in November, but after waiting for a long time, it was rejected in March, a total of 6 months (0) 讚！ | 沛容来了 |
| 作者: 青夏小可爱 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定＆不明 撰寫評論 |
2017-10-07 10:39:35 評論於 Review Speed: 1.0 Experience Sharing: Higher Hit Rate for Submitted Case Reports (0) 讚！ | 青夏小可爱 |
| 作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定＆不明 撰寫評論 |
2017-07-18 15:01:30 評論於 3 points on the edge, hoping to maintain stability, a slight increase would also be good (0) 讚！ | 凌霄高洁 |
| 作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定＆不明 撰寫評論 |
2014-11-19 17:58:49 評論於 First time submitting to this magazine, it has been a full month since submission, feeling nervous, hoping for acceptance! Willing to share experiences with everyone (0) 讚！ | 凌霄高洁 |
| 首頁 上一頁 1 下一頁 末頁 (頁 | |
Contact us
